DR-TB and PMDT

PWB for shorter oral Bedaquiline containing MDR/RR-TB regimen.

DR-TB Services and Functions of Stakeholders

Learn about History of Programmatic Management of Drug Resistant TB (PMDT) in India.

District DR-TB Centre Committee Composition and Functions

• Identify the risk factors associated with hepatotoxicity during treatment with shorter or longer oral multidrug-resistant tuberculosis (MDR-TB) regimens.
• Learn to recognize the signs and symptoms of hepatotoxicity in patients undergoing MDR-TB treatment.
• Develop proficiency in managing hepatotoxicity reactions, including dose adjustments, temporary cessation of offending medications, or alternative regimen selection.

Monitoring of pregnant women on shorter/ longer oral Multidrug-resistant TB (MDR-TB

• Understand the patient flow process for individuals diagnosed with mono/poly drug-resistant tuberculosis (DR-TB), from diagnosis to initiation of treatment.
• Ensure adherence to treatment guidelines and protocols at each stage of the patient flow process.

Distribution of Second-line Drugs from the District Drug Store to the TB Unit Store

• What are Patient Wise Boxes (PWB) for DR-TB Patients?
• Steps involved in preparation of PWD.

• Understand the treatment algorithm for multidrug-resistant (MDR) and rifampicin-resistant (RR) tuberculosis (TB) cases.
• Identify the sequential steps involved in the management of MDR/RR-TB, including drug selection, regimen design, and treatment duration.
• Identify criteria for exclusion.